Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
S-adenosyl-L-methionine
DRUG
4 trials
Sponsors
Maurizio Fava, MD
, University Hospital, Basel, Switzerland
, Mayo Clinic
, Pomeranian Medical University Szczecin
Conditions
Depression
Hepatitis C
Primary Biliary Cirrhosis
Tobacco Dependence
Phase 2
Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine
Completed
NCT00310336
University Hospital, Basel, Switzerland
Hepatitis C
Start: 2006-08-31
End: 2009-09-30
Target: 30
Updated: 2010-10-28
S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
Completed
NCT00722124
Mayo Clinic
Tobacco Dependence
Start: 2008-09-30
End: 2010-06-30
Updated: 2011-09-09
Phase 4
Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Completed
NCT02557360
Pomeranian Medical University Szczecin
Primary Biliary Cirrhosis
Start: 2015-11-30
End: 2017-03-31
Updated: 2017-03-28
Unknown Phase
Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
Completed
NCT00101452
Maurizio Fava, MD
Depression
Start: 2005-04-30
End: 2010-06-30
Updated: 2017-04-04
Related Papers
Effect of S-Adenosyl-L-Methionine on Liver Biochemistry and Quality of Life in Patients with Primary Biliary Cholangitis Treated with Ursodeoxycholic Acid. A Prospective, Open Label Pilot Study
Journal of Gastrointestinal and Liver Diseases
2018-09-13
38 citations
Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression
Frontiers in Psychiatry
2018-09-07
22 citations
Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial
Pharmacopsychiatry
2015-05-26
43 citations
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of<i>S</i>-Adenosyl-<scp>l</scp>-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder
The Journal of Clinical Psychiatry
2013-12-24
144 citations
S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse.
2010-11-08
15 citations